BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2024 11:48:14 AM | Browse: 195 | Download: 994
Publication Name World Journal of Clinical Oncology
Manuscript ID 91481
Country China
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title PD-1 antibody in combination with chemotherapy for the treatment of SMARCA4-deficient advanced undifferentiated carcinoma of the duodenum: Two case reports
Manuscript Source Unsolicited Manuscript
All Author List Yi-Nan Shi, Xiao-Rui Zhang, Wei-Yu Ma, Jing Lian, Yan-Feng Liu, Yi-Fan Li and Wen-Hui Yang
ORCID
Author(s) ORCID Number
Yi-Nan Shi http://orcid.org/0009-0007-5660-4654
Yi-Fan Li http://orcid.org/0000-0002-6378-7635
Wen-Hui Yang http://orcid.org/0000-0002-1452-6789
Funding Agency and Grant Number
Corresponding Author Wen-Hui Yang, PhD, Associate Chief Physician, Department of Gastroenterology and Hepatology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, No. 3 Zhigong Xin Street, Taiyuan 030013, Shanxi Province, China. yangwenhui-10012@163.com
Key Words SMARCA4 deficiency; Undifferentiated carcinomas; Chemotherapy; Programmed death 1; Immune checkpoint inhibitors
Core Tip SMARCA4-deficient malignancies arising from the gastrointestinal tract are rare and have a poor prognosis. We present two patients diagnosed with advanced duodenal undifferentiated carcinoma by immunohistochemical staining for SMARCA4 deficiency and TP53 gene mutations. Patients with high tumor mutational burden responded well to programmed death 1 antibodies in combination with chemotherapy, and those with liver metastases had a worse prognosis.
Publish Date 2024-03-22 11:48
Citation Shi YN, Zhang XR, Ma WY, Lian J, Liu YF, Li YF, Yang WH. PD-1 antibody in combination with chemotherapy for the treatment of SMARCA4-deficient advanced undifferentiated carcinoma of the duodenum: Two case reports. World J Clin Oncol 2024; 15(3): 456-463
URL https://www.wjgnet.com/2218-4333/full/v15/i3/456.htm
DOI https://dx.doi.org/10.5306/wjco.v15.i3.456
Full Article (PDF) WJCO-15-456-with-cover.pdf